CFMS - Earnings announcements

BILLERICA, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2023. First Quarter 2023 Summary Total revenue of $12.8 million, a decrease of 17% year-over-year on a reported and constant currency basis.Product revenue of $12.7 million, a decrease of 15% year-over-year on a reported basis and 14% on a constant currency basis.Conformis hip system revenue of $0.8 million, an increase of 3% year-over-year.Cash and cash equivalents of $37.8 million as of March 31, 2023.   Three months ended March 31,

BILLERICA, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the first quarter ended March 31, 2023, before the market opens on Monday, May 8, 2023. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call at 8:30 a.m. Eastern Time to discuss the financial results and provide a business update. Earnings Call and Webcast Details: The webcast of the earnings call will be live at: Link Directly to Webcast To attend by telephone, please use the information below for dial-in access. Date and Time

BILLERICA, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the fourth quarter and year ended December 31, 2022. Fourth Quarter 2022 Summary Total revenue of $17.4 million, an increase of 13% year-over-year on a reported basis and 14% on a constant currency basis.Product revenue of $14.2 million, a decrease of 7% year-over-year on a reported basis and 6% on a constant currency basis.Hip system revenue of $0.6 million, a decrease of 15% year-over-year.Cash and cash equivalents of $48.7 million as of December 31, 2022.First procedur

BILLERICA, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, provided today a business update and reported preliminary financial results for the fourth quarter and year ended December 31, 2022. Executive Commentary – Mark Augusti, President and CEO "Today we are announcing the launch of our new advertising campaign highlighting our Image-to-Implant Platinum Services program. This campaign focuses on highlighting the benefits of a fully personalized knee to patients and will launch initially in a select number of targeted markets. We are also providing an update of our

BILLERICA, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the fourth quarter and full-year ended December 31, 2022, after the market closes on Wednesday, March 1, 2023. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide a business update. Earnings Call and Webcast Details: The webcast of the earnings call will be live at: Link Directly to Webcast To attend by telephone, please use the information below for dial-in

BILLERICA, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Summary Total revenue of $13.8 million, a decrease of 3% year-over-year on a reported basis and 2% on a constant currency basis.Product revenue of $13.6 million, a decrease of 3% year-over-year on a reported basis and 2% on a constant currency basis.Conformis hip system revenue of $0.6 million, a decrease of 19% year-over-year.Cash and cash equivalents of $59.6 million as of September 30, 2022. Executive Comm

BILLERICA, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Wednesday, November 2, 2022. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call later that day at 4:30 p.m. Eastern Time to discuss the financial results and provide a business update. Earnings Call and Webcast Details: The webcast of the earnings call will be live at: Link Directly to Webcast To attend by telephone, please use the information below for dial

BILLERICA, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Summary Total revenue of $15.3 million. Total revenue in the second quarter of 2021 included significant non-recurring royalty revenue.Product revenue of $15.1 million, remained flat year-over-year on a reported basis and increased 1% on a constant currency basis.Conformis hip system revenue of $0.7 million, a decrease of 18% year-over-year.Cash and cash equivalents of $72.6 million as of June 30, 2022. Ex

BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the second quarter ended June 30, 2022, after the market closes on Monday, August 8, 2022. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call the next day before the market opens on Tuesday, August 9, 2022, at 8:30 a.m. Eastern Time to discuss the financial results and to provide a business update. Earnings Call and Webcast Details: The webcast of the earnings call will be live at: Link Directly to Webcast To attend by telephon

BILLERICA, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2022. First Quarter 2022 Summary Total revenue of $15.6 million, an increase of 12% year-over-year on a reported basis and 13% on a constant currency basis.Product revenue of $14.9 million, an increase of 9% year-over-year on a reported and constant currency basis.Conformis hip system revenue up 18% year-over-year to $0.8 million.Cash and cash equivalents of $82.7 million as of March 31, 2022.Recently completed the 250th Imprint procedure

BILLERICA, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022, before the market opens on Wednesday, May 4, 2022, at approximately 7:00 a.m. Eastern Time. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call also on Wednesday, May 4, 2022, at 8:30 a.m. Eastern Time to discuss the financial results and to provide a business update. The Company will hold its annual meeting of stockholders at 12:00 p.m. Eastern Time on May 4, 2022. Earnings Call and Webcast Details: The webcast of the earnings call will be live at: https://edge.media-server.com/mmc

BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that as mentioned on its Business Update call on January 6, 2022, it will release its financial results for the fourth quarter and fiscal year ended December 31, 2021, after the market closes on Wednesday, March 2, 2022, at approximately 4:00 p.m. Eastern Time. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call also on Wednesday, March 2, 2022, at 4:30 p.m. Eastern Time to discuss the financial results and to provide a business update. The webcast will be live at: https://edge.media-server.com/mmc/p/6vqkixan To attend by telephone, please use the information below

Company Launches Innovative Image-to-Implant® Platinum Services℠ Program to Better Serve Patients and Surgeons BILLERICA, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, today announced preliminary revenue results from its fourth quarter 2021, initial expectations for 2022, and a business update that introduces the Company's new Image-to-Implant® Platinum Services℠ Program to the investor community. Fourth Quarter 2021 – Preliminary Revenue Results The Company expects to report product revenue of approximately $15.3 million for the fourth quarter of 2021.This compar

BILLERICA, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it will provide a business update and initial expectations for 2022 before the market opens on Thursday, January 6, 2022, at approximately 7:00 a.m. Eastern Time. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call also on Thursday, January 6, 2022, at 8:30 a.m. Eastern Time. As announced during its earnings call on November 3, 2021, Conformis will provide a planned business update. Key topics: preliminary revenue results for the fourth quarter of 2021;the initial outlook for 2022 revenue;a general business update; anda question and answer session. The webcas

BILLERICA, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it will release its financial results for the third quarter ended September 30, 2021 after the market closes on November 3, 2021 at approximately 4:00 p.m. Eastern Time. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call also on Wednesday, November 3, 2021, at 4:30 p.m. Eastern Time to discuss the financial results and to provide a business update. The webcast will be live at: https://edge.media-server.com/mmc/p/wvne4ujy To attend by telephone, please use the information below for dial-in access.   When prompted on dial-in, please utilize con